Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy

Metabolism: Clinical and Experimental

Volumn 52, Issue 5, 2003, Pages 605-608

  Moriwaki, Yuji ^a,b,c   Yamamoto, Tetsuya ^a,b,c   Shibutani, Yuhei ^a,b,c   Aoki, Eiji ^a,b,c   Tsutsumi, Zenta ^a,b,c   Takahashi, Sumio ^a,b,c   Okamura, Haruki ^a,b,c   Koga, Masafumi ^a,b,c   Fukuchi, Minoru ^a,b,c   Hada, Toshikazu ^a,b,c  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NISHI KOBE MEDICAL CENTER   (Japan)

^c Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 18; INTERLEUKIN 6; MONOCLONAL ANTIBODY; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; LIPID;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; URINARY EXCRETION; ALBUMINURIA; BLOOD; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; PATHOLOGY; URINE;

ADULT; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-18; INTERLEUKIN-6; LIPIDS; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038748305     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2003.50096     Document Type: Article

References (19)

1. Desfaits A-C, Serri O, Renier G: Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-α production in NIDDM patients after gliclazide treatment. Diabetes Care 21:487-493, 1998
2. Pickup JC, Chusney GD, Thomas SM, et al: Plasma interleukin-6, tumor necrosis factor α and blood cytokine production in type 2 diabetes. Life Sci 67:291-300, 2000
3. Shikano M, Sobajima H, Yoshikawa H, et al: Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron 85:81-85, 2000
4. Mooradian AD, Reed RL, Meredith KE, et al: Serum levels of tumor necrosis factor and IL-1α and IL-1β in diabetic patients. Diabetes 14:63-65, 1991
5. Katsuki A, Sumida Y, Murashima S, et al: Serum levels of tumor necrosis factor- α are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-862, 1998
6. Pfeiffer A, Janott J, Mohlig M, et al: Circulating tumor necrosis factor α is elevated in male but not in female patients with type II diabetes mellitus. Horm Metab Res 29:111-114, 1997
7. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
8. American Diabetes Association: Diabetic nephropathy. Diabetes Care 21:550-553, 1998
9. Yamano T, Higashi T, Nouso K, et al: Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis. Clin Exp Immunol 122:227-231, 2000
10. Shigehara K, Shijubo N, Ohmichi M, et al: Increased levels of interleukin-18 in patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 162:1979-1982, 2000
11. Miyauchi S, Matsuuraa B, Onji M: Increased levels of serum interleukin-18 in Grave's disease. Thyroid 10:815-819, 2000
12. Wong CK, Li EK, Ho CY, et al: Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 39:1078-1081, 2000
13. Endo S, Inada K, Yamada Y, et al: Interleukin-18 (IL-18) levels in patients with sepsis. J Med 31:15-20, 2000
14. Nicoletti F, Conget I, DiMrco R, et al: Serum levels of the interferon-γ inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia 44:309-311, 2001
15. Rothe H, Jenkins N, Copeland N, et al: Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J Clin Invest 99:469-474, 1997
16. Rothe H, Hausmann A, Casteels K, et al: IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. J Immunol 163:1230-1236, 1999
17. Suzuki D, Miyazaki M, Naka R, et al: In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes 44:1233-1238, 1995
18. Fantuzzi G, Reed DA, Dinarello CA: IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor. J Clin Invest 104:761-767, 1999
19. Melnikov VY, Ecder T, Fantuzzi G, et al: Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 107:1145-1152, 2001